421 related articles for article (PubMed ID: 23965626)
1. Mechanism of Trypanosoma brucei gambiense resistance to human serum.
Uzureau P; Uzureau S; Lecordier L; Fontaine F; Tebabi P; Homblé F; Grélard A; Zhendre V; Nolan DP; Lins L; Crowet JM; Pays A; Felu C; Poelvoorde P; Vanhollebeke B; Moestrup SK; Lyngsø J; Pedersen JS; Mottram JC; Dufourc EJ; Pérez-Morga D; Pays E
Nature; 2013 Sep; 501(7467):430-4. PubMed ID: 23965626
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus.
Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E
Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
Cuypers B; Lecordier L; Meehan CJ; Van den Broeck F; Imamura H; Büscher P; Dujardin JC; Laukens K; Schnaufer A; Dewar C; Lewis M; Balmer O; Azurago T; Kyei-Faried S; Ohene SA; Duah B; Homiah P; Mensah EK; Anleah F; Franco JR; Pays E; Deborggraeve S
mBio; 2016 Apr; 7(2):e02198-15. PubMed ID: 27073096
[TBL] [Abstract][Full Text] [Related]
4. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.
Capewell P; Clucas C; DeJesus E; Kieft R; Hajduk S; Veitch N; Steketee PC; Cooper A; Weir W; MacLeod A
PLoS Pathog; 2013; 9(10):e1003686. PubMed ID: 24098129
[TBL] [Abstract][Full Text] [Related]
5. [Molecular dialogue between African trypanosomes and humans].
Pays E
Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
[TBL] [Abstract][Full Text] [Related]
6. Mutual self-defence: the trypanolytic factor story.
Pays E; Vanhollebeke B
Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
[TBL] [Abstract][Full Text] [Related]
7. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.
Capewell P; Cooper A; Clucas C; Weir W; Macleod A
Parasitology; 2015 Feb; 142 Suppl 1(Suppl 1):S108-19. PubMed ID: 25656360
[TBL] [Abstract][Full Text] [Related]
8. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
[TBL] [Abstract][Full Text] [Related]
9. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
[TBL] [Abstract][Full Text] [Related]
10. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.
Vanhollebeke B; Pays E
Mol Microbiol; 2010 May; 76(4):806-14. PubMed ID: 20398209
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.
Kieft R; Capewell P; Turner CM; Veitch NJ; MacLeod A; Hajduk S
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16137-41. PubMed ID: 20805508
[TBL] [Abstract][Full Text] [Related]
12. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Cooper A; Capewell P; Clucas C; Veitch N; Weir W; Thomson R; Raper J; MacLeod A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004903. PubMed ID: 27494254
[TBL] [Abstract][Full Text] [Related]
13. Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei.
Greene AS; Hajduk SL
J Biol Chem; 2016 Feb; 291(6):3063-75. PubMed ID: 26645690
[TBL] [Abstract][Full Text] [Related]
14. Human innate immunity against African trypanosomes.
Pays E; Vanhollebeke B
Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
[TBL] [Abstract][Full Text] [Related]
15. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
16. The human trypanolytic factor: a drug shaped naturally.
Vanhamme L
Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
[TBL] [Abstract][Full Text] [Related]
17. Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.
Kieft R; Stephens NA; Capewell P; MacLeod A; Hajduk SL
Mol Biochem Parasitol; 2012 May; 183(1):8-14. PubMed ID: 22226682
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding.
DeJesus E; Kieft R; Albright B; Stephens NA; Hajduk SL
PLoS Pathog; 2013; 9(4):e1003317. PubMed ID: 23637606
[TBL] [Abstract][Full Text] [Related]
20. The trypanolytic factor of human serum.
Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]